Ping Liu | |
---|---|
Born | 1964 (age 59–60) |
Academic background | |
Alma mater | Anhui University , University of Otago |
Thesis | |
Doctoral advisor | David K. Bilkey |
Academic work | |
Institutions | University of Otago |
Ping Liu (born 1964) [1] is a Chinese New Zealand academic,and is a full professor at the University of Otago,specialising in neurobiology,especially how arginine metabolism affects brain function in normal ageing and in diseases such as schizophrenia and Alzheimer's disease.
Liu is a neurobiologist with a medical background. She completed an MB at Anhui University and then worked for eight years as a geriatrician in China before joining her husband in New Zealand,where he had studied. [2] Liu realised that working as a doctor in New Zealand would be difficult due to the language barrier,so made the decision to retrain as a researcher. [2] She joined the staff of the University of Otago in 1994, [3] and began a PhD in the Department of Psychology,supervised by David Bilkey,the following year. [2] She completed her doctoral thesis,titled Perirhinal cortex contributions to spatial memory in 1998, [1] and rose to full professor in 2020. [4] She is part of the Otago's Brain Health Research Centre. [5]
Liu's research focuses on neurodegenerative disorders such as schizophrenia and Alzheimer's disease,and on the changes in memory,learning and brain metabolism during normal ageing. [4] Liu investigates the metabolic products of the semi-essential amino acid arginine. Liu's research has shown that altered arginine metabolism is associated with both schizophrenia and Alzheimer's disease. One metabolic product of arginine,agmatine,is a possible new neurotransmitter,but its role in learning and memory is as yet poorly understood. [6] Liu's research group uses animal models and post-mortem human brain tissue to investigate how these changed processes lead to disease,and to try to identify possible diagnostic tests and therapeutic targets. [7] In particular,Liu believes that arginine metabolites might present a less-invasive and costly test for Alzheimer's disease than the present diagnostic tests of brain scans and cerebrospinal fluid testing. It might also be possible to diagnose people earlier through such biomarkers. [7] Liu is also investigating whether arginine metabolism differences might be involved in the clinical differences seen between early and late-onset Alzheimer's disease. [7]
Liu's group is also researching the effects of prenatal viral exposure in children. [2]
The entorhinal cortex (EC) is an area of the brain's allocortex, located in the medial temporal lobe, whose functions include being a widespread network hub for memory, navigation, and the perception of time. The EC is the main interface between the hippocampus and neocortex. The EC-hippocampus system plays an important role in declarative (autobiographical/episodic/semantic) memories and in particular spatial memories including memory formation, memory consolidation, and memory optimization in sleep. The EC is also responsible for the pre-processing (familiarity) of the input signals in the reflex nictitating membrane response of classical trace conditioning; the association of impulses from the eye and the ear occurs in the entorhinal cortex.
Arginine is the amino acid with the formula (H2N)(HN)CN(H)(CH2)3CH(NH2)CO2H. The molecule features a guanidino group appended to a standard amino acid framework. At physiological pH, the carboxylic acid is deprotonated (−CO2−) and both the amino and guanidino groups are protonated, resulting in a cation. Only the l-arginine (symbol Arg or R) enantiomer is found naturally. Arg residues are common components of proteins. It is encoded by the codons CGU, CGC, CGA, CGG, AGA, and AGG. The guanidine group in arginine is the precursor for the biosynthesis of nitric oxide. Like all amino acids, it is a white, water-soluble solid.
The cingulate cortex is a part of the brain situated in the medial aspect of the cerebral cortex. The cingulate cortex includes the entire cingulate gyrus, which lies immediately above the corpus callosum, and the continuation of this in the cingulate sulcus. The cingulate cortex is usually considered part of the limbic lobe.
The temporal lobe is one of the four major lobes of the cerebral cortex in the brain of mammals. The temporal lobe is located beneath the lateral fissure on both cerebral hemispheres of the mammalian brain.
Aging of the brain is a process of transformation of the brain in older age, including changes all individuals experience and those of illness. Usually this refers to humans.
In cognitive psychology and neuroscience, spatial memory is a form of memory responsible for the recording and recovery of information needed to plan a course to a location and to recall the location of an object or the occurrence of an event. Spatial memory is necessary for orientation in space. Spatial memory can also be divided into egocentric and allocentric spatial memory. A person's spatial memory is required to navigate around a familiar city. A rat's spatial memory is needed to learn the location of food at the end of a maze. In both humans and animals, spatial memories are summarized as a cognitive map.
Agmatine, also known as 4-aminobutyl-guanidine, was discovered in 1910 by Albrecht Kossel. It is a chemical substance which is naturally created from the amino acid arginine. Agmatine has been shown to exert modulatory action at multiple molecular targets, notably: neurotransmitter systems, ion channels, nitric oxide (NO) synthesis and polyamine metabolism and this provides bases for further research into potential applications.
The entorhinal cortex (EC) is a major part of the hippocampal formation of the brain, and is reciprocally connected with the hippocampus.
Cerebral atrophy is a common feature of many of the diseases that affect the brain. Atrophy of any tissue means a decrement in the size of the cell, which can be due to progressive loss of cytoplasmic proteins. In brain tissue, atrophy describes a loss of neurons and the connections between them. Brain atrophy can be classified into two main categories: generalized and focal atrophy. Generalized atrophy occurs across the entire brain whereas focal atrophy affects cells in a specific location. If the cerebral hemispheres are affected, conscious thought and voluntary processes may be impaired.
The posterior cingulate cortex (PCC) is the caudal part of the cingulate cortex, located posterior to the anterior cingulate cortex. This is the upper part of the "limbic lobe". The cingulate cortex is made up of an area around the midline of the brain. Surrounding areas include the retrosplenial cortex and the precuneus.
The perirhinal cortex is a cortical region in the medial temporal lobe that is made up of Brodmann areas 35 and 36. It receives highly processed sensory information from all sensory regions, and is generally accepted to be an important region for memory. It is bordered caudally by postrhinal cortex or parahippocampal cortex and ventrally and medially by entorhinal cortex.
The biochemistry of Alzheimer's disease, the most common cause of dementia, is not yet very well understood. Alzheimer's disease (AD) has been identified as a proteopathy: a protein misfolding disease due to the accumulation of abnormally folded amyloid beta (Aβ) protein in the brain. Amyloid beta is a short peptide that is an abnormal proteolytic byproduct of the transmembrane protein amyloid-beta precursor protein (APP), whose function is unclear but thought to be involved in neuronal development. The presenilins are components of proteolytic complex involved in APP processing and degradation.
The retrosplenial cortex (RSC) is a cortical area in the brain comprising Brodmann areas 29 and 30. It is secondary association cortex, making connections with numerous other brain regions. The region's name refers to its anatomical location immediately behind the splenium of the corpus callosum in primates, although in rodents it is located more towards the brain surface and is relatively larger. Its function is currently not well understood, but its location close to visual areas and also to the hippocampal spatial/memory system suggest it may have a role in mediating between perceptual and memory functions, particularly in the spatial domain. However, its exact contribution to either space or memory processing has been hard to pin down.
In human neuroanatomy, brain asymmetry can refer to at least two quite distinct findings:
Type 3 diabetes is a proposed pathological linkage between Alzheimer's disease and certain features of type 1 and type 2 diabetes. Specifically, the term refers to a set of common biochemical and metabolic features seen in the brain in Alzheimer's disease, and in other tissues in diabetes; it may thus be considered a "brain-specific type of diabetes." It was recognized at least as early as 2005 that some features of brain function in Alzheimer's disease mimic those that underlie diabetes. However, the concept of type 3 diabetes is controversial, and as of 2021 it was not an officially recognized diagnosis.
Alcohol-related brain damage alters both the structure and function of the brain as a result of the direct neurotoxic effects of alcohol intoxication or acute alcohol withdrawal. Increased alcohol intake is associated with damage to brain regions including the frontal lobe, limbic system, and cerebellum, with widespread cerebral atrophy, or brain shrinkage caused by neuron degeneration. This damage can be seen on neuroimaging scans.
Dirk De Ridder is a Belgian neurosurgeon. He is a professor of neurosurgery at the University of Otago in Dunedin, New Zealand. De Ridder spends half his time in New Zealand and half in Belgium, involved in setting up a dedicated neuromodulation clinic.
Helen C. Murray is a New Zealand neuroscientist and ice hockey forward who currently serves as captain of the New Zealand national team. She made her debut with the senior national team at the 2013 IIHF Women's World Championship Division II, and was named captain in 2016. Her research focuses on Alzheimer's disease, where she splits her time between the American National Institutes of Health and the University of Auckland Centre for Brain Research. Her 2017 doctoral thesis was titled Plasticity in the Human Alzheimer’s Disease Brain.
KarXT is an investigational oral dual-drug fixed-dose combination of xanomeline and trospium. It is undergoing a phase 3 clinical trial for the treatment of schizophrenia. Xanomeline is a functionally preferring muscarinic M4 and M1 receptor agonist that readily passes into the central nervous system (CNS) to stimulate these receptors in key areas of the brain. Trospium is a non-selective muscarinic antagonist that does not cross into the CNS and reduces peripheral cholinergic side effects associated with xanomeline.
Lynette Joy Tippett is a New Zealand professor of psychology at the University of Auckland, specialising in neurodegenerative diseases.